Latest Posts
About This Stock
More About This Stock
Read
Shares Of Zafgen Fell 60% After Reporting Another Patient Death For Obesity Trial
Article By:
Terry Chrisomalis
Wednesday, December 2, 2015 10:30 PM EDT
The obesity trial is being turn to treat patients with a rare disease known as Prader-Will Syndrome. This syndrome causes the ability for patients to be hungry all the time, which causes the foundation for long-term obesity.